New combined therapy helps extend lives of men with prostate cancer

Medical Xpress

Center

High Factuality

New combined therapy helps extend lives of men with prostate cancer

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.